SCHEMBL13762986

SCHEMBL13762986

Cc1cc(CCOCc2ccccc2)cs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 3/20 0.39
DAO P14920 1/20 0.38
LMNA P02545 1/20 0.36
NAAA Q02083 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 1/20 0.36
KCNH2 Q12809 1/20 0.36
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
MAPK14 Q16539 1/20 0.35
LTA4H P09960 1/20 0.35
TACR1 P25103 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13763145 0.86 TSHR (0.56) TSHRTDP1L3MBTL1ALDH1A1DAO
SCHEMBL13145294 0.80 TDP1 (0.40) TSHRTDP1L3MBTL1ALDH1A1DAO
SCHEMBL1066576 0.76 TSHR (0.67) TSHRTDP1L3MBTL1ALDH1A1NAAA
SCHEMBL12809367 0.75 DAO (0.40) TSHRTDP1L3MBTL1ALDH1A1DAO
Hydrochloric Acid SCHEMBL1409425 0.74 TSHR (0.64) TSHRTDP1L3MBTL1ALDH1A1NAAA
Water SCHEMBL28780406 0.74 TSHR (0.64) TSHRTDP1L3MBTL1ALDH1A1NAAA
SCHEMBL14003858 0.73 CALM1 (0.50) ALDH1A1DAOLMNAKDM4EPOLB
SCHEMBL13763027 0.72 TP53 (0.50) TSHRTDP1L3MBTL1ALDH1A1LMNA
SCHEMBL14327850 0.71 TSHR (0.48) TSHRTDP1L3MBTL1ALDH1A1NAAA
SCHEMBL28506052 0.71 KCNH2 (0.57) TSHRTDP1L3MBTL1ALDH1A1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572786-B2 Irritable bowel syndrome; tachykinin mediated condition such as schizophrenia, emesis, anxiety, depression, irritable bowel syndrome, circadian rhythm disturbances, pain, neurogenic inflammation, asthma, micturition disorder or nociception JANSSEN PHARMACEUTICA, N.V. (BE) 2009-08-11 US disclosed